Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102

NCT07527975 · clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
14
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Rocket Pharmaceuticals Inc.